ArticlesArchiveAboutEditorial BoardAuthor Guidelines
Call for papersThe 2026 special issue on Climate & Health is open for submissions.Learn more
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En…
Sara Pusceddu, Milena Vitali, Eva Haspinger, Luca Tavecchio, Riccardo Giovannetti, Andrea Bille, Laura Concas, Marina Garassino, Massimo Milione, Filippo de Braud, Roberto Buzzoni
An estimated 25% to 30% of all neuroendocrine tumors (NETs) have their origin in the bronchial tree and into the lungs. Although lung NETs account for less than 1% of all pulmonary malignancies, the incidence of these neoplasms has risen precipitously since t…
Giuseppe Preziosi, Jude A. Oben, Giuseppe Fusai
Background : Pancreatic cancer is associated with a very severe prognosis and identification of risk factors is essential. Diabetes and obesity are both established risk factors, and they both cause hyperinsul e nemia. With this review we wished to appraise t…
Vincenzo Ravo, Domenico Borrelli, Sara Falivene, Rossella Di Franco, Matteo Muto, Angela Argenone, Valentina Borzillo, Fabrizio Cammarota, Paolo Muto
Aim : To evaluate the predictability of toxicity analyzing the dose-volume histograms (DVHs) and to verify the effectiveness of preventive measures limiting side toxicity considering the evolution of the radiation techniques for prostate cancer treatment. Mat…
Seung-Jun Seo, Jae-Kun Jeon, Eun-Ju Jeong, Won-Seok Chang, Gi-Hwan Choi, Jong-Ki Kim
Background: Proton-impact metallic nanoparticles, inducing low-energy electrons emission and characteristic X-rays termed as Coulomb nanoradiator effect (CNR), are known to produce therapeutic enhancement in proton treatment on experimental tumors. The purpos…
Michael Back, Shaun Clifford, Helen Wheeler, Thomas Eade
Aims: The EORTC - NCI study investigating the addition of temozolomide trial to standard radiation therapy has demonstrated improved duration of survival in patients with Glioblastoma multiforme (GBM). With longer survival duration, there is the potential for…
Zakiya Salem Al-Rahbi, Ramamoorthy Ravichandran, Johnson Pichy Binukumar, Cheriyithmanjiyil Antony Davis, Namrata Satyapal, Zahid Al-Mandhari
Objectives of present study are a) to compare the planning and delivery aspects of five different techniques, planned by a) forward, inverse planning and electronic tissue compensation methods; and b) to evaluate and verify the accuracy of the planning system…
Mouad Edderkaoui, Edwin Thrower
Smoking is a major risk factor for chronic pancreatitis and pancreatic cancer. However, the mechanisms through which it causes the diseases remain unknown. In the present manuscript we reviewed the latest knowledge gained on the effect of cigarette smoke and…
Dipankar Das, Harsha Bhattacharjee, Kasturi Bhattacharjee, Prerana S. Tahiliani, Pankaj Bhattacharyya, Manabjyoti Barman, Sumita Sarma Barthakur, Panna Deka, Apurba Deka, Rajashree Paul
Retinoblastoma has varied presentations. As age advances in retinoblastoma, the undifferentiated tumour is the common appearance. Apoptosis in retinoblastoma in an untreated case can give us a clue about the tumour biology. Efferocytosis in intraocular tumour…
Emad Moussa, Mohamed Fawzy, Alaa Younis, Maged El Shafei, Mohamed Saad Zaghloul, Naglaa El Kinaai, Amal Refaat, Noha Atta, Alaa El Haddad
Background: Neuroblastoma (NB) is remarkable for its wide spectrum of clinical behavior and biological characteristics in relation to outcome. The use of aggressive therapy , including autologous hematopoietic stem cell transplantation (HSCT) and the addition…
Reham Abdulmoniem, Tarek Haikal, Hossam Darwiesh
Background: There is an underutilization of postoperative radiation therapy (PORT) in renal cell carcinoma (RCC) following radical nephrectomy (RN). The main reason for that is the lack of strong evidence and the contradictory data in the literature regarding…
No articles in this issue.
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En… All articles are open access under a CC BY 4.0 licence, with authors retaining copyright.
Authors submit their manuscript, metadata, and declarations through the portal. There is no submission fee.
The editorial office screens the manuscript for scope, completeness, and formatting before assigning a handling editor.
At least two independent reviewers evaluate the manuscript under single-blind review. Where revisions are required, authors respond point by point.
On acceptance the article processing charge is invoiced and the CC BY 4.0 copyright handover is signed.
The article is copyedited, typeset, and given a DOI, then publishes open access with a permanent link.
Manuscripts must be original and not under consideration elsewhere. Submit in Microsoft Word or LaTeX with figures at 300 dpi minimum. Structure research articles as Abstract, Introduction, Methods, Results, Discussion, and References.
Use the journal's numbered (Vancouver) reference style. Cite sources consecutively in the order they appear, and ensure every reference is complete and retrievable.
Declare all funding sources, conflicts of interest, and ethical approvals (including informed consent and animal-care statements where applicable).